Nucleome Therapeutics Limited

12109297

active

Private Limited Company

england wales

Companies House

Health Score

65 / 100

Some Concerns

25/30

Filing

0/30

Financial

40/40

Risk

No risk factors detected.

Details

NUCLEOME THERAPEUTICS LIMITED, INVENTA, OXFORD, OX2 0HA

Incorporated 17/07/2019

Compliance

Last accounts

31/12/2024

small

Next accounts due

30/09/2026

On track

Confirmation statement

Last: 16/08/2025

Due 30/08/2026

On track

Industry

72110

Research and experimental development on biotechnology

Officers

James Raymond Hughes

director · Since 17/07/2019

ASSOCIATE PROFESSOR AT UNIVERSITY OF OXF

BRITISH,IRISH · UNITED KINGDOM · Age 57

Dr Jonathan Paul Hepple

director · Since 30/11/2020

VENTURE CAPITALIST

BRITISH · UNITED KINGDOM · Age 55

Also on 1 other board

Dr Rana Abdul Raouf Al-Hallaq

director · Since 21/10/2022

PARTNER, PFIZER VENTURES EXECUTIVE DIREC

AMERICAN · UNITED STATES · Age 51

Also on 1 other board

Dr Bauke Anninga

director · Since 21/10/2022

VENTURE CAPITALIST

DUTCH · NETHERLANDS · Age 39

Also on 1 other board

Dr Russell George Greig

director · Since 06/09/2023

CHAIR

AMERICAN,BRITISH · UNITED STATES · Age 74

John Davis

director · Since 15/02/2024

PHYSICIAN

AMERICAN · UNITED STATES · Age 64

Mark Bodmer

director · Since 24/07/2024

CEO

BRITISH · UNITED KINGDOM · Age 69

Dr Nadiya Ishnazarova

director · Since 04/12/2025

RUSSIAN · NETHERLANDS · Age 34

Persons with Significant Control

Oxford Science Enterprises Plc

25–50% votes

46, Woodstock Road, Oxford, OX2 6HT

Reg: 09093331 · Companies House · Corporate

Notified 02/08/2019

Former PSCs

James Raymond Hughes

Ceased 29/07/2019